Actively Recruiting

Age: 12Years +
All Genders
NCT06813443

Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation

Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-02-07

700

Participants Needed

3

Research Sites

252 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study aims to identify new diagnostic and prognostic markers for CMP that can help predict disease progression. In particular, the study will focus on microRNAs (miRNAs) and spatial transcriptomics, which are emerging techniques that may provide insights into the underlying disease mechanisms. By understanding these markers, the investigators hope to improve the way the investigators diagnose and manage CMP, particularly in terms of predicting progression to heart failure or heart transplantation. The study will evaluate patients with hypertrophic cardiomyopathy (e.g., sarcomeric forms, Anderson-Fabry disease, AL, and TTR cardiac amyloidosis), dilated cardiomyopathy and arrhythmogenic cardiomyopathy. These patients will undergo clinical evaluations, including ECG, echocardiograms, CMR, biopsy analysis, and genetic testing, as well as molecular studies such as transcriptomics and miRNA analysis. This comprehensive approach aims to identify potential new biomarkers for diagnosing and predicting the disease course.

CONDITIONS

Official Title

Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation

Who Can Participate

Age: 12Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with CMP according to current international guidelines
  • Age 212 years at the time of diagnosis
  • Obtaining informed consent from the patient and the parent or legal guardian (in the case of patients aged < 18 years)
Not Eligible

You will not qualify if you...

  • none

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Emilia-Romagna/Bologna, Italy, 40138

Actively Recruiting

2

Dipartimento di Scienze Toraciche Cardiovascolari, Fondazione Policlinico Universitario A. Gemelli IRCSS di Roma

Roma, Lazio/Roma, Italy, 00161

Not Yet Recruiting

3

Azienda Ospedaliero-Universitaria Careggi di Firenze

Florence, Toscana/Firenze, Italy, 50134

Not Yet Recruiting

Loading map...

Research Team

E

Elena Biagini, MD, PhD

CONTACT

S

Silvia Palmieri, M. Sc.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here